Generium

IBC Generium | 477 followers on LinkedIn. IBC Generium is a scientific research company with a mission to develop safe and effective biotechnology-based medical products and cell-based technologies to the stage of industrial application. Our highly qualified scientific staff and state-of-the-art facilities allow us to design and develop virtually any recombinant protein, monoclonal antibody or cell-based product, suitable for industrial manufacturing, preclinical and clinical studies. We draw our ideas for novel and generic medical products from the products developed by our own company as well as those of others in the biotech and pharmaceutical industry, suitable for licensing in the Russian Federation.